HealthTronics has made an unsolicited bid to buy Endocare for $26.9 million in cash. The offer represents a 20% premium over Endocare’s closing stock price on August 6th. HealthTronics’ product portfolio includes […]
Clarient Q2 Revenues Up 71%
Not wanting to break a winning streak, Clarient delivered its 16th consecutive quarter of quarterly revenue growth. The company posted revenues of $16.9 million in its most recent quarter, a 71% increase […]
Inovio Biomedical and VGX Pharmaceuticals to Merge
Citing synergies, Inovio Biomedical and VGX Pharmaceuticals have announced merger plans. Inovio’s electroporation technology uses brief, controlled electrical pulses to increase cellular uptake of gene expression in DNA-based treatments; this enhances the […]
Bitter Ally Buys Bankrupt Immunicon
Veridex, LLC, a subsidiary of Johnson & Johnson, will acquire Immunicon for $31 million in cash. Immunicon filed for bankruptcy on Wednesday; the announcement sent shares tumbling to from $.27 to $.09. […]
Upgraded Enlarged Prostate Treatment Catheter from Urologix: CTC Advance
This week, the OneMedPlace team is down in Orlando attending the American Urological Association’s annual meeting. We’ll be capturing some great video footage from the floor which we’ll be sharing later this […]
[Video Profile] Interview with James Datin, Executive VP and Managing Director of Safeguard Scientifics
Safeguard Scientifics is a holding company that invests in growth-stage life sciences and technology. In addition to capital, Safeguard provides strategic, operational and management resources to its portfolio companies. As a public […]
Myriad Goes Direct (Again)
Myriad Genetic Laboratories develops and markets proprietary predictive and personalized medicine products. This includes the poorly branded BRACAnalysis, to assess a woman’s risk of developing breast or ovarian cancer based on detection […]
[Video Profile] Interview with Dr. Randal Chase, CEO of ImmunoVaccine Technologies
ImmunoVaccine Technologies (IVT) is a private biotechnology company developing therapeutic cancer and infectious disease vaccines. VacciMax technology is based on a novel approach to the use of liposomes. While liposomes typically contribute […]
